232 related articles for article (PubMed ID: 2974719)
21. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
Amar L; Kircik LH
J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592
[TBL] [Abstract][Full Text] [Related]
22. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
Kellett N; West F; Finlay AY
Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
[TBL] [Abstract][Full Text] [Related]
24. Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris.
Burke B; Eady EA; Cunliffe WJ
Br J Dermatol; 1983 Feb; 108(2):199-204. PubMed ID: 6218815
[TBL] [Abstract][Full Text] [Related]
25. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
Langner A; Chu A; Goulden V; Ambroziak M
Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerance of a miconazole-benzoyl peroxide cream combination versus a benzoyl peroxide gel in the topical treatment of acne vulgaris.
Flückiger R; Furrer HJ; Rufli T
Dermatologica; 1988; 177(2):109-14. PubMed ID: 2971582
[TBL] [Abstract][Full Text] [Related]
27. Management of comedonal acne vulgaris with fixed-combination topical therapy.
Gold MH; Baldwin H; Lin T
J Cosmet Dermatol; 2018 Apr; 17(2):227-231. PubMed ID: 29380941
[TBL] [Abstract][Full Text] [Related]
28. A comparison of Cleocin T Solution, Cleocin T Gel, and placebo in the treatment of acne vulgaris.
Ellis CN; Gammon WR; Stone DZ; Heezen-Wehner JL
Cutis; 1988 Sep; 42(3):245-7. PubMed ID: 2971512
[TBL] [Abstract][Full Text] [Related]
29. Benzoyl peroxide in the treatment of acne vulgaris: a double-blind, multi-centre comparative study of 'Quinoderm' cream and 'Quinoderm' cream with hydrocortisone versus their base vehicle alone and a benzoyl peroxide only gel preparation.
Jaffé GV; Grimshaw JJ; Constad D
Curr Med Res Opin; 1989; 11(7):453-62. PubMed ID: 2528439
[TBL] [Abstract][Full Text] [Related]
30. Comparative trial of benzoyl peroxide versus benzoyl peroxide with urea in inflammatory acne.
Prince RA; Harris JM; Maroc JA
Cutis; 1982 Jun; 29(6):638-40, 644-5. PubMed ID: 6213380
[TBL] [Abstract][Full Text] [Related]
31. Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris.
Mills OH; Kligman AM; Pochi P; Comite H
Int J Dermatol; 1986 Dec; 25(10):664-7. PubMed ID: 2948929
[TBL] [Abstract][Full Text] [Related]
32. Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability.
Ko HC; Song M; Seo SH; Oh CK; Kwon KS; Kim MB
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):245-50. PubMed ID: 19438817
[TBL] [Abstract][Full Text] [Related]
33. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Gonzalez P; Vila R; Cirigliano M
J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
[TBL] [Abstract][Full Text] [Related]
34. A double-blind clinical trial with a lotion containing 5% benzoyl peroxide and 2% miconazole in patients with acne vulgaris.
Mesquita-Guimarães J; Ramos S; Tavares MR; Carvalho MR
Clin Exp Dermatol; 1989 Sep; 14(5):357-60. PubMed ID: 2532986
[TBL] [Abstract][Full Text] [Related]
35. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
Keating GM
Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
[TBL] [Abstract][Full Text] [Related]
36. Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel.
Harper JC
J Drugs Dermatol; 2012 Dec; 11(12):1440-5. PubMed ID: 23377514
[TBL] [Abstract][Full Text] [Related]
37. Imidazoles and benzoyl peroxide: a comparative trial of two treatment schedules.
Van Neste D; Tennstedt D; Decroix J
Dermatologica; 1986; 172(2):108-12. PubMed ID: 2936636
[TBL] [Abstract][Full Text] [Related]
38. A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients.
Xu JH; Lu QJ; Huang JH; Hao F; Sun QN; Fang H; Gu J; Dong XQ; Zheng J; Luo D; Li FQ; Wang G; Gu H; Tian HQ; Yang HL; Xi LY; Li M; Zheng M; Wu Y; Tu YT; He YL; Zhao G; Sheng WX; Li J; Hamedani AG
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1176-82. PubMed ID: 27075705
[TBL] [Abstract][Full Text] [Related]
39. The BEST study: evaluating efficacy by selected demographic subsets.
Fernandez-Obregon A; Davis MW
Cutis; 2003 Feb; 71(2 Suppl):18-26. PubMed ID: 12630671
[TBL] [Abstract][Full Text] [Related]
40. Motretinide versus benzoyl peroxide in the treatment of acne vulgaris.
Lassus A; Juvakoski T; Lauharanta J
Dermatologica; 1984; 168(4):199-201. PubMed ID: 6233188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
